• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.

作者信息

GROB D, HARVEY A M

出版信息

Bull Johns Hopkins Hosp. 1952 Aug;91(2):124-36.

PMID:14944967
Abstract
摘要

相似文献

1
Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.促肾上腺皮质激素（ACTH）和可的松给药对重症肌无力患者的影响以及长期使用可的松期间重症肌无力发病情况的报告。
Bull Johns Hopkins Hosp. 1952 Aug;91(2):124-36.
2
[Treatment of severe cases of myasthenia; action of ACTH and cortisone, considerations apropos of three cases].
Arq Neuropsiquiatr. 1956 Mar;14(1):28-36.
3
Clinical evaluation of the effect of adrenocorticotrophic hormone and cortisone on myasthenia gravis.
J Lab Clin Med. 1950 Dec;36(6):966-7.
4
Clinical-evaluation of ACTH and cortisone in myasthenia gravis.促肾上腺皮质激素和可的松在重症肌无力中的临床评估
Neurology. 1951 Mar-Apr;1(2):145-52. doi: 10.1212/wnl.1.3.145.
5
Remission in a case of myasthenia gravis following the use of acth.
N Y State J Med. 1952 Jun 15;52(12):1565.
6
The use of adrenocorticotrophic hormone in the treatment of myasthenia gravis.
Minn Med. 1951 Dec;34(12):1160-4.
7
[Myasthenia gravis. Recent findings and their therapeutic consequences].[重症肌无力。最新研究发现及其治疗意义]
Dtsch Med Wochenschr. 1979 Oct 5;104(40):1415-20. doi: 10.1055/s-0028-1129112.
8
Myasthenia gravis treated with ACTH.
Nurs Times. 1967 Dec 15;63(50):1695-6.
9
[Bilirubinemia and rheumatism; dangers of ACTH and cortisone].
Schweiz Med Wochenschr. 1952 Jun;82(26):686-7.
10
Adrenal insufficiency in myasthenia gravis. A possible cause of adrenocorticotropic hormone (ACTH) treatment failure.重症肌无力中的肾上腺皮质功能不全。促肾上腺皮质激素（ACTH）治疗失败的一个可能原因。
Bull Los Angeles Neurol Soc. 1972 Jul;37(3):124-30.

引用本文的文献

1
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.诱发或导致重症肌无力病情恶化的药物：最新进展
J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537.
2
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.糖皮质激素治疗后重症肌无力恶化：有何证据？系统评价。
J Neurol. 2021 Dec;268(12):4573-4586. doi: 10.1007/s00415-020-10264-0. Epub 2020 Oct 16.
3
[ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].[促肾上腺皮质激素及皮质类固醇对神经系统疾病的治疗]
Dtsch Z Nervenheilkd. 1963 Jul 10;185:121-49.
4
[Clinical aspects of myopathy].[肌病的临床方面]
Dtsch Z Nervenheilkd. 1955;173(5-6):455-81.
5
Controversies about the treatment of myasthenia gravis.重症肌无力治疗方面的争议。
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.
6
Immunopathology of acetylcholine receptors in myasthenia gravis.重症肌无力中乙酰胆碱受体的免疫病理学
Springer Semin Immunopathol. 1982;5(4):389-412. doi: 10.1007/BF01857427.
7
Benefit from adrenocorticotrophin in myasthenia gravis.重症肌无力患者使用促肾上腺皮质激素的获益。
J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):412-5. doi: 10.1136/jnnp.37.4.412.
8
[The pathogenesis of myasthenia gravis as an immunological problem].[重症肌无力作为免疫问题的发病机制]
Klin Wochenschr. 1970 Jan 1;48(1):4-13. doi: 10.1007/BF01486122.
9
Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.促肾上腺皮质激素（ACTH）治疗重症肌无力：大剂量短期及维持治疗
J Neurol Neurosurg Psychiatry. 1969 Aug;32(4):290-6. doi: 10.1136/jnnp.32.4.290.